Skip to content
Nonprofiteer
← PODIATRY SOCIETY OF THE STATE OF NEW YORK

Form 990 for tax year 2022

Filed by PODIATRY SOCIETY OF THE STATE OF NEW YORK.

Totals

Total revenue
$420,744
Total expenses
$498,145
Contributions and grants received
$169,625
Grants paid
$11,250
Program service revenue
$246,859
Investment income
$2,760
Other revenue
$1,500
Total assets, end of year
$194,312
Total liabilities, end of year
$64,110
Net assets or fund balances, end of year
$130,202
Program services expenses (Part IX)
$225,724
Management and general expenses
$229,526
Fundraising expenses
$42,895
Program service expenses (Part III)
$225,724

Program services were 45.3% of total expenses calculated — Part IX's program-services column over total expenses, both as filed.

Line items

Every line the filer filed in Parts VIII, IX and X, as filed and in filed order. Blank columns are left out, and the lines are not forced to add up to the totals above.

Revenue

Part VIII, the statement of revenue.

  • 1f · All other contributions, gifts and grants

    $169,625

  • 2a · Program service revenue: CLINICAL CONFERENCE

    total $185,026 · related or exempt $185,026

  • 2b · Program service revenue: EDUCATION ASESSMENT

    total $61,833 · related or exempt $61,833

  • 3 · Investment income

    total $2,760 · excluded $2,760

  • 11a · Other revenue: MISCELLANEOUS

    total $1,500 · excluded $1,500

  • 11e · Other revenue, total

    $1,500

Functional expenses

Part IX, the statement of functional expenses.

  • 1 · Grants to domestic organizations and governments

    total $11,250 · program services $11,250

  • 11b · Fees: legal

    total $32,445 · management and general $32,445

  • 11c · Fees: accounting

    total $23,375 · management and general $23,375

  • 11f · Fees: investment management

    total $2,128 · management and general $2,128

  • 12 · Advertising and promotion

    total $15,021 · program services $7,511 · management and general $6,008 · fundraising $1,502

  • 21 · Payments to affiliates

    total $130,000 · program services $65,000 · management and general $52,000 · fundraising $13,000

  • 24a · Other expenses: CLINICAL CONFERENCE EXP

    total $276,320 · program services $138,160 · management and general $110,528 · fundraising $27,632

  • 24b · Other expenses: BANK CHARGES

    total $7,606 · program services $3,803 · management and general $3,042 · fundraising $761

Balance sheet

Part X, book values.

  • 1 · Cash, non-interest-bearing

    beginning of year $20,734 · end of year $76,408

  • 2 · Savings and temporary cash investments

    beginning of year $148,958

  • 4 · Accounts receivable

    beginning of year $2,296 · end of year -$11,753

  • 10a · Land, buildings and equipment: cost or other basis

    $7,205

  • 10b · Land, buildings and equipment: accumulated depreciation

    $7,205

  • 10c · Land, buildings and equipment, net

    beginning of year $0 · end of year $0

  • 11 · Investments: publicly traded securities

    beginning of year $129,851 · end of year $129,657

  • 17 · Accounts payable and accrued expenses

    beginning of year $40,882 · end of year $64,110

  • 25 · Other liabilities

    beginning of year $7,000

  • 27 · Net assets without donor restrictions

    beginning of year $248,957 · end of year $125,202

  • 28 · Net assets with donor restrictions

    beginning of year $5,000 · end of year $5,000

Mission and programs · 2022

Mission

THE FOUNDATION FOR PODIATRIC MEDICINE, A NONPROFIT 501(C)(3) ORGANIZATION, WAS ESTABLISHED IN 1986. THE MISSION OF THE FOUNDATION FOR PODIATRIC MEDICINE IS TO OFFER CONTINUING MEDICAL EDUCATION, PROFESSIONAL DEVELOPMENT AND PUBLIC INFORMATION SERVICES.

  • IN KEEPING WITH ITS MISSION, THE FOUNDATION FOR PODIATRIC MEDICINE HONORS THE TRADITION OF ADVANCING THE PROFESSION THROUGH EDUCATION. ITS PREMIER EDUCATIONAL EVENT, THE CLINICAL CONFERENCE, GATHERS THE BEST AND BRIGHTEST FACULTY TO PRESENT THE VITAL EDUCATIONAL AND CLINICAL INFORMATION THAT IS SO IMPORTANT TO PODIATRISTS. THE CLINICAL CONFERENCE ENSURES BOTH QUALITY PATIENT CARE AND THE CONTINUING GROWTH OF THE PROFESSION.

    Expenses $225,724 · Grants $11,250 · Revenue $246,859

As filed on the 2022 return.

Listed in Part VII

  • Dr William Spielfogel

    PRESIDENT

    Total calculated
    $0
    Hours/week
    2
  • Dr Charles Lombardi

    VICE PRESIDENT

    Total calculated
    $0
    Hours/week
    2
  • Dr Daniel Keating

    TREASURER

    Total calculated
    $0
    Hours/week
    2
  • Dr Lawrence Santi

    SECRETARY

    Total calculated
    $0
    Hours/week
    2
  • Dr Nicholas Argerakis

    OFFICER

    Total calculated
    $0
    Hours/week
    2
  • Dr Emilio Goez

    OFFICER

    Total calculated
    $0
    Hours/week
    2
  • Dr James Hanna

    OFFICER

    Total calculated
    $0
    Hours/week
    2
  • Dr Roy Defrancis

    OFFICER

    Total calculated
    $0
    Hours/week
    2
  • Mr Dan Kline

    EXECUTIVE DIRECTOR

    Total calculated
    $0
    Hours/week
    10 + 30 related
  • Mr Matthew Feldman

    EX OFFICIO

    Total calculated
    $0
    Hours/week
    30

Compensation is as filed in Part VII: reportable pay from this organization and from related organizations, other compensation, and hours per week. The total, marked calculated, is our sum of the three dollar columns, with a blank column counted as $0; the form itself has no total. On a Form 990-EZ the columns are Part IV's instead, and on a Form 990-PF Part VIII's — compensation, contributions to benefit plans, and expense account — and the total sums those.

Grants on this return

Related organizations on this return

Schedule R Part II: tax-exempt organizations related to the filer by control. It does not record shared board members or money.

Provenance

Return type
form_990
Tax year
2022
Filed
11 March 2024
IRS schema version
2022v5.0
Source object
202410719349301276

Check it against the return as filed: the GivingTuesday Data Lake hosts a public copy of the original XML.

The source document this was parsed from is served over the API, which is where bulk and document access live.